Maartens G - Search Results

1

Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB.

Pandie M, Wiesner L, McIlleron H, Hughes J, Siwendu S, Conradie F, Variava E, Maartens G. Pandie M, et al. Among authors: maartens g. J Antimicrob Chemother. 2016 Apr;71(4):1037-40. doi: 10.1093/jac/dkv447. Epub 2016 Jan 7. J Antimicrob Chemother. 2016. PMID: 26747099

2

Antiretroviral therapy and drug interactions.

Cohen K, Andrews S, Maartens G. Cohen K, et al. Among authors: maartens g. S Afr Med J. 2001 Oct;91(10):816-9. S Afr Med J. 2001. PMID: 11732449 Review. No abstract available.

3

Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

Sanne I, Mommeja-Marin H, Hinkle J, Bartlett JA, Lederman MM, Maartens G, Wakeford C, Shaw A, Quinn J, Gish RG, Rousseau F. Sanne I, et al. Among authors: maartens g. J Infect Dis. 2005 Mar 15;191(6):825-9. doi: 10.1086/428093. Epub 2005 Feb 10. J Infect Dis. 2005. PMID: 15717255 Clinical Trial.

4

High prevalence of subtherapeutic plasma concentrations of efavirenz in children.

Ren Y, Nuttall JJ, Egbers C, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM. Ren Y, et al. Among authors: maartens g. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):133-6. doi: 10.1097/QAI.0b013e31805c9d52. J Acquir Immune Defic Syndr. 2007. PMID: 17417100 Clinical Trial.

5

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.

McIlleron H, Meintjes G, Burman WJ, Maartens G. McIlleron H, et al. Among authors: maartens g. J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75. doi: 10.1086/518655. J Infect Dis. 2007. PMID: 17624828 Review.

6

Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.

Cohen K, van Cutsem G, Boulle A, McIlleron H, Goemaere E, Smith PJ, Maartens G. Cohen K, et al. Among authors: maartens g. J Antimicrob Chemother. 2008 Feb;61(2):389-93. doi: 10.1093/jac/dkm484. Epub 2007 Dec 19. J Antimicrob Chemother. 2008. PMID: 18096560

7

Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis.

Ren Y, Nuttall JJ, Egbers C, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM. Ren Y, et al. Among authors: maartens g. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):566-9. doi: 10.1097/QAI.0b013e3181642257. J Acquir Immune Defic Syndr. 2008. PMID: 18197120

8

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G. Boulle A, et al. Among authors: maartens g. JAMA. 2008 Aug 6;300(5):530-9. doi: 10.1001/jama.300.5.530. JAMA. 2008. PMID: 18677025

9

Effect of rifampicin on efavirenz pharmacokinetics in HIV-infected children with tuberculosis.

Ren Y, Nuttall JJ, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM. Ren Y, et al. Among authors: maartens g. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):439-43. doi: 10.1097/QAI.0b013e31819c33a3. J Acquir Immune Defic Syndr. 2009. PMID: 19223781 Clinical Trial.

10

Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa.

Cohen K, Grant A, Dandara C, McIlleron H, Pemba L, Fielding K, Charalombous S, Churchyard G, Smith P, Maartens G. Cohen K, et al. Among authors: maartens g. Antivir Ther. 2009;14(5):687-95. Antivir Ther. 2009. PMID: 19704172 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters